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Background: We previously described poor survival among cardiac resynchronization (CRT) recipients with renal insufficiency (RI). It is not known if 
CRT differentially impacts survival depending upon baseline renal function.
Methods: 787 pts who received CRT-defibrillators (CRT-D) in whom baseline glomerular filtration rate (GFR, in mL/min/m2) was determined using 
the Modification of Diet in Renal Disease equation were divided into groups: A (GFR ≥60), B (GFR 30-59), and C (GFR<30). 88 HF patients with 
unsuccessful LV lead implant who received standard defibrillators (SD) comprised a control cohort and were similarly stratified by GFR. Survival 
among CRT-D and SD pts within each GFR stratum was compared using the U.S. Social Security Death Index.
Results: CRT-D pts experienced a significant survival advantage over SD pts only within group B (Figure), and this remained significant after 
correcting for age, which was the only difference between the cohorts. There was no survival advantage among CRT-D recipients in groups A or C. 
Groups B (+2.1 ± 12.9) and C (+7.9 ± 17.5) had significantly greater GFR improvement (p<0.0001) compared to group A, which had an overall GFR 
decrease (-5.5 ± 19.2).
Conclusions: CRT provides survival benefit beyond that conferred by a defibrillator in pts with moderate RI, whereas its impact in pts with normal 
renal function or severe RI is less clear. CRT may also improve renal function in pts with both moderate and severe RI. Prospective studies in CRT-
eligible pts with RI are warranted.
